comparemela.com

Latest Breaking News On - Host webcast - Page 1 : comparemela.com

Sachem Capital Reports First Quarter 2024 Results – Revenues Grew 17.0% To $17.2 Million

Sachem Capital Reports First Quarter 2024 Results – Revenues Grew 17.0% To $17.2 Million
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United-states
American
John-villano
Nasdaq
Sachem-capital-corp
Real-estate-investment-trust
Exchange-commission-on
Haven-bank
Company-to-host-webcast
Needham-bank
Federal-reserve
Host-webcast

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures

Supernus Pharmaceuticals to Host Webcast to Review Interim Data from Ongoing Open-Label Phase IIa Study of SPN-817 for Treatment-Resistant Seizures
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Timothyc-dec
Peter-vozzo
Jacka-khattar
Exchange-commission
Supernus-pharmaceuticals
Company-investor-relations
Nasdaq
Supernus-pharmaceuticals-inc
Securities-exchange
Host-webcast
Review-interim-data
Ongoing-open-label-phase

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results

Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Belite-bio
Julie-fallon
Jennifer-wu
Instagram
Belite-bio-inc
Company-investor-relatons
Twitter
Facebook
Linkedin
Host-webcast
Discuss-first-quarter
Investor-relatons

G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights

01.05.2024 - - Achieved $14.1 Million in Net Revenue from Sales of COSELA (trilaciclib) for First Quarter 2024 - - Reaffirmed 2024 Net COSELA Revenue Guidance of $60 to $70 Million - - Announced That Updated Efficacy Results from Phase 2 Trial of Trilaciclib .

Japan
Ukraine
Jack-bailey
Johnw-umstead
Drug-administration-on
Pepper-bio-inc
Investor-relations-corporate-communications
Therapeutics-inc
Exchange-commission
Nasdaq
Twitter
Drug-administration

Heritage Global to Announce First Quarter 2024 Results and Host Webcast on Thursday, May 9, 2024

Heritage Global to Announce First Quarter 2024 Results and Host Webcast on Thursday, May 9, 2024
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Exchange-commission
Nasdaq
Heritage-global-inc
While-the-company
Announce-first-quarter
Host-webcast
Earnings-conference
Investor-relations
Heritage-global
Industrial-assets
Private-securities-litigation-reform-act
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.